• All
  • Executive Search
  • Finance
  • M&A
  • Views

New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL, Sept. 7, 2022 /PRNewswire/ - Ortho Regenerative Technologies Inc., (CSE: ORTH)  ( OTCQB: ORTIF) ("Ortho" or the "Company") a clinical-stage orthobiologics company focused...

Press release         Ecully, September 7, 2022 – 8 pm Half-year results 2022 Initial benefits of redeployment Acceleration of activity driven by Distimp sales and contributionsGood operating performance orientationStrong cash position of €15.3 million allowingNo additional issuance of Convertible Bonds until the...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced healthcare industry...